| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.01 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | 0.16 | 0.01 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.02 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.02 |